Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01604135 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial

Study acronym: CXL-RCT
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Apr 2025 to Apr 2027v8
  2. Primary and study completion dates: Apr 2024 to Apr 2025v7
  3. Primary and study completion dates: Apr 2022 to Apr 2024v6
  4. Primary and study completion dates: May 2019 to Apr 2022
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 200 to confirmed 36
    • Site details revised
    v5
  5. Primary and study completion dates: May 2017 to May 2019v4
Show 2 earlier versionsHide 2 earlier versions
  1. Re-verified, no change to tracked fieldsv3
  2. Primary and study completion dates: May 2015 to May 2017
    • Eligibility criteria expanded, about 27 words
    • Publications revised (4)
    • Study description shortened, about 1 word
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine whether corneal collagen crosslinking is effective in the treatment of progressive keratoconus.
Trial Details
NCT Number NCT01604135
Lead Sponsor Sahlgrenska University Hospital
Collaborators: Göteborg University
Conditions
(from sponsor)		 Keratoconus
Related terms Keratoconus
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov